12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Dexamethasone: SPA submitted

InSite submitted an updated SPA to FDA for an upcoming Phase III trial to evaluate AzaSite Plus and DexaSite with the agency's 8 minor recommendations....

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >